Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. - Chung, C. H.; Aulino, J.; Muldowney, N. J.; Hatakeyama, H.; Baumann, J.; Burkey, B.; Netterville, J.; Sinard, R.; Yarbrough, W. G.; Cmelak, A. J.; Slebos, R. J.; Shyr, Y.; et al. (Annals of Oncology, 2010)